<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0040">
 <element-citation publication-type="other" id="rf0040">
  <person-group person-group-type="author">
   <name>
    <surname>U.S. Food and Drug Administration</surname>
   </name>
  </person-group>
  <article-title>Recommendations for Investigational COVID-19 Convalescent Plasma</article-title>
  <ext-link ext-link-type="uri" xlink:href="https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma" id="ir0015" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma</ext-link>
  <year>2020</year>
  <comment>(accessed 05 June 2020)</comment>
 </element-citation>
</ref>
